Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/ijms23031328
Keywords
apoptosis; cell death; tumour; cancer; cancer therapy; immune system; repair; regeneration; macrophage; extracellular vesicle
Funding
- Wellcome Trust [107940/Z/15/Z]
- Cancer Research UK and Engineering and Physical Sciences Council UK [EDDCPJTn100003]
- Wellcome Trust [107940/Z/15/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
Cancer growth is characterized by an imbalance between cell gain and cell loss, with high-grade cancers often having high levels of apoptosis. While cell-autonomous apoptosis serves as a tumor suppressor mechanism, limited apoptosis can promote cell survival and resistance to therapy by conditioning the tumor microenvironment. Understanding the implications of cell death programs in tumor biology is crucial for cancer treatment.
Cancer growth represents a dysregulated imbalance between cell gain and cell loss, where the rate of proliferating mutant tumour cells exceeds the rate of those that die. Apoptosis, the most renowned form of programmed cell death, operates as a key physiological mechanism that limits cell population expansion, either to maintain tissue homeostasis or to remove potentially harmful cells, such as those that have sustained DNA damage. Paradoxically, high-grade cancers are generally associated with high constitutive levels of apoptosis. In cancer, cell-autonomous apoptosis constitutes a common tumour suppressor mechanism, a property which is exploited in cancer therapy. By contrast, limited apoptosis in the tumour-cell population also has the potential to promote cell survival and resistance to therapy by conditioning the tumour microenvironment (TME)-including phagocytes and viable tumour cells-and engendering pro-oncogenic effects. Notably, the constitutive apoptosis-mediated activation of cells of the innate immune system can help orchestrate a pro-oncogenic TME and may also effect evasion of cancer treatment. Here, we present an overview of the implications of cell death programmes in tumour biology, with particular focus on apoptosis as a process with double-edged consequences: on the one hand, being tumour suppressive through deletion of malignant or pre-malignant cells, while, on the other, being tumour progressive through stimulation of reparatory and regenerative responses in the TME.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available